Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical APIs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel dual-HPLC method achieves >99.8% purity for Cetrorelix. Eliminates precipitation risks, ensuring scalable production and cost reduction for pharmaceutical manufacturers.
Novel enzymatic route for 2-deoxy-2,2-difluoro-3,5-dibenzoyl-D-ribofuranose offers high yield and purity, replacing hazardous hydrogenation for reliable supply.
Patent CN113651800A reveals a high-yield route for Oxitinib Mesylate, offering cost reduction and supply chain reliability for pharmaceutical manufacturers.
Discover the patented CN101973932A synthesis route for Bisacodyl. Achieve 99% purity with reduced acetic anhydride usage and efficient phenol recovery for cost-effective manufacturing.
Patent CN103601777A details a high-purity capecitabine preparation method using isopropyl ether crystallization, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN112979723B details a novel Schiff base purification strategy for Gemcitabine intermediates, ensuring superior purity and yield for pharmaceutical manufacturing.
Advanced synthesis of pazopanib hydrochloride intermediates via safe reductive amination. Cost-effective, scalable routes for API manufacturing supply chains.
Patent CN114249690A reveals a novel DBU-catalyzed route for Roxadustat. Achieve high purity and reduced manufacturing costs with our scalable pharmaceutical intermediate solutions.
Patent CN113603636A details a cost-effective Nickel-catalyzed route for 2-isopropyl-3-amino-4-methylpyridine, offering significant supply chain advantages.
Novel 5-step synthesis of KRAS G12D inhibitor intermediate 1 from L-proline. Reduces cost and complexity compared to ozonolysis routes.
Patent CN115894503A details a streamlined 5-step synthesis of a key pyrrolizine intermediate from L-proline, offering significant cost reduction and safer processing for API manufacturing.
Patent CN112047829B reveals a cost-effective Grignard carboxylation route for high-purity Alectinib intermediates, offering significant supply chain advantages.
Patent CN114853838B reveals a low-cost, high-yield preparation method for abiraterone acetate, offering significant supply chain advantages for pharmaceutical manufacturers.
Patent CN111440151A details a streamlined 3-step synthesis of Pralsetinib using Rieke Zinc coupling, offering high purity >99.6% and reduced manufacturing costs.
Novel preparation method improves purity and yield. Green chemistry approach reduces toxicity. Reliable supply chain partner for oncology APIs.
Patent CN103319311A details a high-efficiency iridium-catalyzed route for (1S)-1-(2,6-dichloro-3-fluorophenyl)ethanol, offering superior ee values and scalability for API production.
Discover a novel industrial route for Apalutamide intermediates using copper catalysis. This patent-backed method ensures high purity, safety, and cost-effective manufacturing.
Advanced patent CN107954919B reveals a green Fischer indole route for Rucaparib intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel route for Imrecoxib via dihydrofuranone intermediate. Eliminates chromium toxicity, reduces cost, and ensures supply continuity for API manufacturing.
Advanced purification of Abiraterone acetate via oxalate salt formation. Eliminates column chromatography, ensures >99.5% purity, and offers scalable manufacturing solutions.